Borderline smooth muscle tumors of the uterus

Obstetrics and Gynecology Clinics of North America
Naciye Mulayim, Fatih Gucer

Abstract

At present, decision regarding where to place a uterine smooth muscle tumor that deviates from the most obvious leiomyoma and leiomyosarcoma groups still depends on time-honored conventional criteria. The focus of categorization should be the clinical outcome and not nosology. To improve accuracy in predicting clinical behavior, a multivariate approach is needed. This involves combining background clinical information, intraoperative and gross findings,multiple relevant morphologic criteria, and immunohistochemical studies. The authors believe that in future, as the number of cases with intermediate clinical outcome and morphologic features increases, and as molecular markers of prognosis are studied, managing these tumors will become more objective.

References

Jun 1, 1992·Human Pathology·S G Hilsenbeck, D C Allred
Jan 1, 1992·American Journal of Clinical Pathology·R A Prayson, W R Hart
Oct 1, 1990·American Journal of Clinical Pathology·S F Cramer, A Patel
Mar 1, 1989·American Journal of Obstetrics and Gynecology·K KawaguchiT Mori
Jan 1, 1988·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·H J NorrisN S Irey
Jan 1, 1985·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·A J Tiltman
Feb 1, 1995·Current Opinion in Obstetrics & Gynecology·B J Quade
Jun 1, 1994·The American Journal of Surgical Pathology·S W BellM R Hendrickson
Feb 1, 1993·Gynecologic Oncology·K E KunzelG d'Ablaing
Sep 1, 1996·Histopathology·M D JeffersE M Macaulay
Feb 1, 1997·The American Journal of Surgical Pathology·W R Hart
Jan 19, 1999·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Y L ZhaiS Fujii
Feb 19, 1999·Baillière's Clinical Obstetrics and Gynaecology·J Crow
Feb 19, 1999·Baillière's Clinical Obstetrics and Gynaecology·T Eldar-Geva, D L Healy
Feb 19, 1999·Baillière's Clinical Obstetrics and Gynaecology·C P West
Dec 22, 1999·Journal of Clinical Pathology·W G McCluggageM Y Walsh
Feb 9, 2000·Human Pathology·L TietzeS Merkelbach-Bruse
Apr 11, 2000·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·R L Kempson, M R Hendrickson
May 24, 2000·European Radiology·N GandolfoC Martinoli
Aug 29, 2001·Pathology·J ScurryD Fortune
Apr 7, 2004·Fertility and Sterility·Klaus BodnerKlaus Mayerhofer
Dec 14, 2004·Gynecologic Oncology·Barbara Bodner-AdlerKlaus Mayerhofer

❮ Previous
Next ❯

Citations

Nov 8, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R BerrettaG B Nardelli
May 6, 2014·Actas dermo-sifiliográficas·A D Lozano SalazarJ J Ríos-Martín
Apr 24, 2012·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Rui GuanMingjuan Xu
Apr 5, 2011·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Bo-Sung YoonHyun Park
Dec 30, 2014·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Yavuz E ŞükürRuşen Aytaç
Apr 5, 2013·The American Journal of Surgical Pathology·Diana LimEsther Oliva

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.